Pulmonary rehabilitation has established itself as a vital and core therapy for people with chronic lung disease. Significant improvements are seen in several patient outcomes, for the thousands ...

Background Conventional measures to evaluate COPD may fail to capture systemic problems, particularly musculoskeletal weakness and cardiovascular disease. Identifying these manifestations and ...

Objective Leukaemia is the most common cancer of childhood, accounting for a third of cases. In order to assist clinicians in its early detection, we systematically reviewed all existing data on its ...

Finerenone mitigates clinical events and symptoms regardless of chronic obstructive pulmonary disease (COPD) status in heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), ...

4. Christenson SA, Steiling K, van den Berge M, Hijazi K, Hiemstra PS, Postma DS, et al. Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive ...

Cite this: Pharmacology and Clinical Efficacy of Erdosteine in Chronic Obstructive Pulmonary Disease - Medscape - Dec 01, 2007. Abstract and Introduction Overview of the Market ...

SAN FRANCISCO and SUZHOU, China, June 4, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

clinical presentation Stroke in patients with Chagas disease presents clinically according to embolic events, which mainly affect the cortical zones and anterior circulation 7 , 26 . Clinical features ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology ...

Sanofi and Regeneron have reported that the Phase III AERIFY-1 trial of the fully human monoclonal antibody itepekimab in former smokers who have inadequately controlled chronic obstructive pulmonary ...